We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Altria's Smoke-Free Business Become Its Next Growth Engine?
Read MoreHide Full Article
Key Takeaways
Altria's on! nicotine pouch shipments rose 13.3% to 47.8 million cans in third-quarter 2026.
Nicotine pouches captured 61.2% of the oral tobacco category, while on!'s retail share increased to 8.3%.
Altria's oral tobacco adjusted operating income fell 3.7% to $443 million amid higher costs and promotions.
Altria Group, Inc. (MO - Free Report) continues to strengthen the smoke-free portfolio, with nicotine pouches emerging as a key growth opportunity. The expanding on! franchise, supported by product innovation, enhanced retail visibility and brand-building investments, remains central to the company's efforts to establish a sustainable smoke-free business.
The nicotine pouch category continues to gain traction, accounting for 61.2% of the oral tobacco category in third-quarter 2026, up 5.8 percentage points year over year. Altria's on! reported shipment volumes increased 13.3% to 47.8 million cans, while on! retail share of the oral tobacco category edged up 0.1 percentage point to 8.3%. This improvement came despite a 21.6% increase in retail price to $4.90 and elevated competitive investments.
Product expansion remains another important focus. Altria expanded on! PLUS 12-milligram offerings nationwide across mint, wintergreen and tobacco varieties. New Blueberry Mint and Mango Pineapple flavors, alongside the planned Watermelon Mint introduction in November, further broaden the portfolio. Premium retail positioning in stores representing approximately 90% of Helix's volume supports product visibility and consumer engagement.
However, profitability remains a challenge for the broader oral tobacco segment. Adjusted operating companies income declined 3.7% to $443 million, reflecting lower shipment volumes, higher costs and promotional investments. The expanding on! portfolio and continued innovation in smoke-free products remain central to Altria's efforts to achieve long-term profitable growth.
Altria's Peers Step Up Smoke-Free Expansion
Philip Morris International Inc. (PM - Free Report) continues to advance smoke-free growth through IQOS, ZYN and VEEV. Smoke-free products contributed more than 40% of third-quarter 2026 net revenues, while shipments increased 2.7%. Philip Morris recorded 7.1% growth in IQOS adjusted in-market sales and 61.6% growth in VEEV shipments. Continued product innovation and portfolio expansion strengthen Philip Morris’ long-term smoke-free growth strategy.
Turning Point Brands, Inc. (TPB - Free Report) is accelerating smoke-free growth through FRE and ALP nicotine pouches. Third-quarter 2026 Modern Oral net sales surged 102.9% to $74.4 million, contributing 49.2% of total sales. Turning Point Brands is expanding retail distribution, targeting more than 70% growth in chain-store count in 2026. However, higher marketing investments continue to pressure profitability as Turning Point Brands scales the business.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have gained 15.6% in the past three months compared with the industry’s growth of 6.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 13.01X, down from the industry’s average of 16.04X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2026 and 2027 earnings implies year-over-year growth of 5.2% and 3.3%, respectively.
Image: Bigstock
Will Altria's Smoke-Free Business Become Its Next Growth Engine?
Key Takeaways
Altria Group, Inc. (MO - Free Report) continues to strengthen the smoke-free portfolio, with nicotine pouches emerging as a key growth opportunity. The expanding on! franchise, supported by product innovation, enhanced retail visibility and brand-building investments, remains central to the company's efforts to establish a sustainable smoke-free business.
The nicotine pouch category continues to gain traction, accounting for 61.2% of the oral tobacco category in third-quarter 2026, up 5.8 percentage points year over year. Altria's on! reported shipment volumes increased 13.3% to 47.8 million cans, while on! retail share of the oral tobacco category edged up 0.1 percentage point to 8.3%. This improvement came despite a 21.6% increase in retail price to $4.90 and elevated competitive investments.
Product expansion remains another important focus. Altria expanded on! PLUS 12-milligram offerings nationwide across mint, wintergreen and tobacco varieties. New Blueberry Mint and Mango Pineapple flavors, alongside the planned Watermelon Mint introduction in November, further broaden the portfolio. Premium retail positioning in stores representing approximately 90% of Helix's volume supports product visibility and consumer engagement.
However, profitability remains a challenge for the broader oral tobacco segment. Adjusted operating companies income declined 3.7% to $443 million, reflecting lower shipment volumes, higher costs and promotional investments. The expanding on! portfolio and continued innovation in smoke-free products remain central to Altria's efforts to achieve long-term profitable growth.
Altria's Peers Step Up Smoke-Free Expansion
Philip Morris International Inc. (PM - Free Report) continues to advance smoke-free growth through IQOS, ZYN and VEEV. Smoke-free products contributed more than 40% of third-quarter 2026 net revenues, while shipments increased 2.7%. Philip Morris recorded 7.1% growth in IQOS adjusted in-market sales and 61.6% growth in VEEV shipments. Continued product innovation and portfolio expansion strengthen Philip Morris’ long-term smoke-free growth strategy.
Turning Point Brands, Inc. (TPB - Free Report) is accelerating smoke-free growth through FRE and ALP nicotine pouches. Third-quarter 2026 Modern Oral net sales surged 102.9% to $74.4 million, contributing 49.2% of total sales. Turning Point Brands is expanding retail distribution, targeting more than 70% growth in chain-store count in 2026. However, higher marketing investments continue to pressure profitability as Turning Point Brands scales the business.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have gained 15.6% in the past three months compared with the industry’s growth of 6.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 13.01X, down from the industry’s average of 16.04X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2026 and 2027 earnings implies year-over-year growth of 5.2% and 3.3%, respectively.
Altria currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.